
Neoxal 50mg Injection
Marketer
RPG Life Sciences Ltd
Salt Composition
Oxaliplatin (50mg)
Overview Neoxal 50mg Injection
Oxaliplatin 50mg injection treats colorectal cancer by inhibiting cancerous cell proliferation. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's instructions; incorrect usage or overdosage can lead to severe adverse effects. Therapeutic benefits may take weeks or months to manifest; discontinue only under medical guidance. Common side effects include nausea, tiredness, vomiting, and diarrhea. This medication can reduce blood cell counts (red and white), increasing infection risk. Serious allergic reactions, such as mouth sores, rash, itching, or breathing difficulties, necessitate immediate medical attention. Regular blood tests monitor blood cell levels, along with heart, liver, and uric acid levels. Inform your doctor of pre-existing heart, liver, or kidney conditions, or any concurrent medications, particularly those for infections, before commencing treatment. Drug interactions are possible; disclose all medications to your healthcare provider. This medication is contraindicated during pregnancy and breastfeeding. It can cause male infertility; sperm freezing should be discussed with your doctor. Dizziness may occur; avoid driving after administration.
Uses of Neoxal 50mg Injection
Colorectal cancer
Major Benefits of Neoxal 50mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Neoxal 50mg Injection:
- Nausea
- Fatigue
- Anemia (low number of red blood cells)
- Vomiting
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Low blood platelets
- Increased liver enzymes
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Stomatitis (Inflammation of the mouth)
How to use Neoxal 50mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Neoxal 50mg Injection works:
Oxaliplatin 50mg injection is a chemotherapy agent. Its mechanism of action involves disrupting the cancerous cells' DNA and RNA, thereby inhibiting their proliferation and growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Neoxal 50mg Injection may be unsafe; physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Administering Neoxal 50mg Injection during pregnancy poses a confirmed risk to the fetus. Its use should be avoided, except in exceptional, life-threatening circumstances where the potential benefits clearly outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administration of Neoxal 50mg Injection is contraindicated while breastfeeding due to potential infant toxicity.
DrivingUNSAFE
Administering Neoxal 50mg Injection may induce adverse reactions impacting driving capabilities. Oxaliplatin therapy similarly elevates the likelihood of dizziness, nausea, vomiting, and other neurological manifestations affecting gait; consequently, driving may be compromised.
KidneyCAUTION
Exercise caution when administering Neoxal 50mg Injection to individuals with severe renal impairment; dosage modification may be necessary. Consult a physician for guidance. Data regarding Neoxal 50mg Injection use in such patients is limited. Dosage alterations are not advised for patients exhibiting mild to moderate kidney dysfunction.
LiverCAUTION
Administering Neoxal 50mg Injection requires careful consideration in individuals with hepatic impairment. Dosage modification for Neoxal 50mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Neoxal 50mg Injection :
Omit a Neoxal 50mg Injection? Seek your physician's advice.
Facts to Know About Neoxal 50mg Injection
| Label | Value |
|---|---|
| Chemical Type | Platinum Equivalents |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Platinum-based Anticancer Agents |
